1 | SLC22A3, SLC47A1
|
| Organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter in the placenta and fetal tissues: expression profile and fetus protective role at different stages of gestation.
|
| Ahmadimoghaddam D, Zemankova L, Nachtigal P, Dolezelova E, Neumanova Z, Cerveny L, Ceckova M, Kacerovský M, Micuda S, Staud F.
|
| Biol Reprod 88(3):55. doi: 10.1095/biolreprod.112.105064. Print 2013 Mar.
2013
|
2 | HNF1B, NUDT11, SLC22A3
|
| Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.
|
| Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, Kido M, Yamamoto T, Petrozziello G, Stack EC, Lis R, Kantoff PW, Loda M, Sartor O, Egawa S, Tewari AK, Hahn WC, Freedman ML.
|
| Proc Natl Acad Sci U S A 109(28):11252-7. doi: 10.1073/pnas.1200853109. Epub 2012 Jun 22.
2012
|
3 | LPA, LPAL2, SLC22A3
|
| Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease.
|
| Trégouët DA, König IR, Erdmann J, Munteanu A, Braund PS, Hall AS, Grosshennig A, Linsel-Nitschke P, Perret C, DeSuremain M, Meitinger T, Wright BJ, Preuss M, Balmforth AJ, Ball SG, Meisinger C, Germain C, Evans A, Arveiler D, Luc G, Ruidavets JB, Morrison C, van der Harst P, Schreiber S, Neureuther K, Schäfer A, Bugert P, El Mokhtari NE, Schrezenmeir J, Stark K, Rubin D, Wichmann HE, Hengstenberg C, Ouwehand W; Wellcome Trust Case Control Consortium; Cardiogenics Consortium, Ziegler A, Tiret L, Thompson JR, Cambien F, Schunkert H, Samani NJ.
|
| Nat Genet 41(3):283-5. Epub 2009 Feb 8.
2009
|
4 | SLC22A3
|
| The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway.
|
| Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K.
|
| Proc Natl Acad Sci U S A 106(19):8043-8. Epub 2009 Apr 29.
2009
|
5 | SLC22A1, SLC22A3
|
| Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
|
| Nies AT, Koepsell H, Winter S, Burk O, Klein K, Kerb R, Zanger UM, Keppler D, Schwab M, Schaeffeler E.
|
| Hepatology 50(4):1227-40. doi: 10.1002/hep.23103.
2009
|
6 | SLC22A1, SLC22A11, SLC22A2, SLC22A3, SLC22A4, SLC22A6, SLC22A7, SLC22A8
|
| Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney.
|
| Ogasawara K, Terada T, Motohashi H, Asaka J, Aoki M, Katsura T, Kamba T, Ogawa O, Inui K.
|
| J Hum Genet 53(7):607-14. Epub 2008 Apr 15. 2008
|
7 | SLC22A3
|
| Caki-1 cells as a model system for the interaction of renally secreted drugs with OCT3.
|
| Glube N, Langguth P.
|
| Nephron Physiol 108(2):p18-28. Epub 2008 Feb 4.
2008
|
8 | SLC22A1, SLC22A2, SLC22A3, SLC29A4
|
| The organic cation transporters (OCT1, OCT2, EMT) and the plasma membrane monoamine transporter (PMAT) show differential distribution and cyclic expression pattern in human endometrium and early pregnancy decidua.
|
| Bottalico B, Noskova V, Pilka R, Larsson I, Domanski H, Casslén B, Hansson SR.
|
| Mol Reprod Dev 74(10):1303-11.
2007
|
9 | SLC22A3
|
| Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
|
| Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iwata N, Inada T, Ozaki N.
|
| Alcohol Clin Exp Res 30(10):1644-9.
2006
|
10 | SLC22A1, SLC22A2, SLC22A3
|
| Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
|
| Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslén B, Marsál K, Hansson SR.
|
| Placenta 25(6):518-29.
2004
|
11 | SLC22A3
|
| Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3).
|
| Lazar A, Grundemann D, Berkels R, Taubert D, Zimmermann T, Schomig E.
|
| J Hum Genet 48(5):226-30. Epub 2003 Apr 09. 2003
|
12 | SLC22A3
|
| Regulation of human extraneuronal monoamine transporter (hEMT) expressed in HEK293 cells by intracellular second messenger systems.
|
| Martel F, Keating E, Calhau C, Grundemann D, Schomig E, Azevedo I.
|
| Naunyn Schmiedebergs Arch Pharmacol 364(6):487-95. 2001
|
13 | SLC22A2, SLC22A3
|
| Gene structures of the human non-neuronal monoamine transporters EMT and OCT2.
|
| Grundemann D, Schomig E.
|
| Hum Genet 106(6):627-35. 2000
|
14 | SLC22A3
|
| Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27.
|
| Verhaagh S, et al.
|
| Genomics 55(2):209-18. 1999
|
15 | SLC22A3
|
| Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.
|
| Kekuda R, et al.
|
| J Biol Chem 273 : 15971-15979. 1998
|
16 | SLC22A3
|
| Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain.
|
| Wu X, et al.
|
| J Biol Chem 273 : 32776-32786. 1998
|
17 | SLC22A1, SLC22A2, SLC22A3, SLC22A4, SLC22A5
|
| Molecular cloning and characterization of a novel liver-specific transport protein.
|
| Simonson GD, Vincent AC, Roberg KJ, Huang Y, Iwanij V.
|
| J Cell Sci 107 ( Pt 4):1065-72. 1994
|